Details for Patent: 10,513,497

Which drugs does patent 10,513,497 protect, and when does it expire?

Patent 10,513,497 protects ATTRUBY and is included in one NDA.

This patent has thirty-eight patent family members in seventeen countries.

Summary for Patent: 10,513,497

Title:	Process for preparing AG-10, its intermediates, and salts thereof
Abstract:	Provided herein are improved processes for the preparation of a compound of Formula IX (AG-10). Also provided herein are pharmaceutically acceptable salts of Formula I and Formula Ib as well as crystalline types of Formula IX (AG-10). The processes described herein provide improved yields and efficiency, while the pharmaceutically acceptable salts and crystalline forms provide unexpected pharmacokinetic properties. Other features and aspects of the present disclosure will be apparent to a person of skill in the art upon reading the remainder of the specification.
Inventor(s):	Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh, Robert Zamboni
Assignee:	Eidos Therapeutics Inc
Application Number:	US15/932,327
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 10,513,497

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bridgebio Pharma	ATTRUBY	acoramidis hydrochloride	TABLET;ORAL	216540-001	Nov 22, 2024		RX	Yes	Yes				Y

International Family Members for US Patent 10,513,497

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018222739
Australia	2024204057
Brazil	112019016935